The Conference is a part of Israel’s 15th National Life Sciences and Technology Week and is being held May 24th to 26th at the David Intercontinental Hotel in Tel Aviv, Israel. Gene Saragnese, Chairman and CEO of MedyMatch Technology is scheduled to speak two times at the conference. First on Tuesday, May 24, 2016, at 4:30 PM – 5:30 PM as part of the CNS Starter Showcase Neurology Track, chaired by Dr. Yael Fuchs Shlomai, Braininnovations Program Manager.
The second opportunity to hear Gene present at the conference, will be on May 26, 2016, from 11:50 am – 12:50 am as part of a panel discussion on image analysis, hosted by Dr. Michal Rosen-Zvi, Director, Health Informatics, IBM Research – Haifa.
The Biomed conference is the preeminent event for the Israeli life sciences industry, attracting leading members of the healthcare industry from around the globe. It comprises group discussions, panel presentations, product demonstrations, and networking opportunities, all designed to encourage business collaborations. Attendees are able to experience firsthand the entrepreneurial spirit which is a basis of Israel’s vibrant life sciences community. Prior conferences have hosted over 6,000 industry senior executives, scientists, and engineers, including approximately 1,000 participants from over 45 countries and in excess of 4,500 one-on-one meetings.
“We are excited to have been selected by two great companies, IBM Research and Pfizer to participate in their respective panels at the BioMed conference this year”, said Gene Saragnese, Chairman & CEO of MedyMatch Technology. “This is the largest annual meeting of the Israeli life science industry and attracts people from around the world who are looking for groundbreaking technology.”
About MedyMatch Technology, Ltd.
MedyMatch utilizes advanced cognitive analytics and artificial intelligence to deliver real-time decision support tools to improve clinical outcomes in acute medical scenarios. The foundation of clinical discovery and value creation lies in the deep clinical understanding of how to diagnose disease, utilizing the right data (electronic medical record, medical imaging, and genomic data). MedyMatch’s vision includes an innovative approach in re-defining ‘capacity in healthcare’ by applying advanced analytic technologies in the emergency room setting to prognosticate downstream cost of care outcomes. The MedyMatch team of artificial intelligence, machine learning, deep learning, and algorithmic experts along with its medical and scientific advisory boards are achieving breakthroughs in standards of cost and care.